Items with tag "neurology"

News

Progranulin shortage could cause frontotemporal dementia

In a recent study in Human Molecular Genetics, researchers from VIB  and KU Leuven led by Prof. Philip Van Damme, reveal a novel function for progranulin in lysosomes: it acts as chaperone of the …

Read more

Epilog Launches EEG Analysis Tool

Epilog, a spin-off of imec and Ghent university, announced the introduction of their first CE-approved product, Epilog PreOp. Epilog PreOp provides automated EEG analysis to localize epileptic bra…

Read more

Protein clumps cause ALS and FTLD

Scientists from Belgium, the UK and the US have identified new processes that form protein “clumps” that are characteristic of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degenera…

Read more

Human neurons in mouse brains advance Alzheimer’s research

Cells behave differently when removed from their environments, just as cells that develop in cultures do not behave like cells in living creatures. To study the effects of Alzheimer’s disease in a…

Read more

Mitochondrial lipids as potential targets in early onset Parkinson’s disease

A team of researchers led by Patrik Verstreken (VIB–KU Leuven) have identified an underlying mechanism in early onset Parkinson’s. Using flies, mice and patient cells, the team focused on cardioli…

Read more

ADx NeuroSciences receives 850.000 EUR support from Flemish Government for tracking brain disorders

Brain injuries, dementia and other neurological problems are often noticed too late. The damage is irrevocable. ADX Neurosciences S.A. is committed to developing biomarkers that can detect, with a…

Read more

ADx NeuroSciences teams up with Japanese partner

ADx NeuroSciences has signed a collaborative R&D agreement with the Japanese Nipro Corporation. The companies will jointly develop next-generation in vitro diagnostics for Alzheimer’s disease. The…

Read more

New strategic VIB - BioPontis Alliance for Rare Diseases

The VIB has announced its first research project in collaboration with the Biopontis Alliance for Rare Diseases. The study is aimed at developing a treatment for Charcot-Marie-Tooth disease and is…

Read more

Breakthrough in understanding dystonia

Are cellular lipids the missing link between a faulty gene and a neurological disorder?   Researchers at VIB-KU Leuven have managed to get a clearer view on the roots of dystonia, a n…

Read more

Patent discussion knocks down UCB shares

Investors aren’t pleased with the news that UCB’s patent on its epilepsy medicine Vimpat is under assault again. The company’s shares dropped 6% when it was revealed that the US generic pharmaceut…

Read more

Regeneron's anti-NGF mAb meets Phase II/III endpoint

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) said fasinumab (REGN475) met the primary endpoint of significantly improving pain relief vs. placebo in a Phase II/III study to treat moderate to sever…

Read more

36 million euros for neurostimulation of spinal cord

The Swiss-Dutch company G-therapeutics, a spin-off from École Polytechnique Fédérale de Lausanne (EPFL), has announced that it received €36 million to develop and bring a realistic therapeutic sol…

Read more

ADx NeuroSciences shifts into higher gear

Plenty of good news for ADx NeuroSciences. Today, the Ghent-based Alzheimer specialist has announced the end of its third capital round as well as a new agreement with their American partner Quant…

Read more

Apitope receives 12 million euros from Wales

The Belgian-British biotech company Apitope, which started as a spin-off of the Hasselt University in Diepenbeek, gets 12 million euros from an investor in Wales. It concerns the Wales Life Scienc…

Read more

Insights

Reversed Brexit: £250 million for Bart De Strooper's dementia research

Reversed Brexit: £250 million for Bart De Strooper's dementia research

The UK has pledged a budget of £250 million to the creation of the UK Dementia Research Institute (DRI). The institute hopes to assemble top-notch neurodegenerative research from around the countr…

Read more

Partnering for a better mental health

Partnering for a better mental health

To address the challenges of drug development, solid strategic partnerships are needed. On the Janssen partner day, the company showcased an ongoing partnership with the University of Antwerp in m…

Read more

Alzheimer's, ALS or a brain injury: ADx neurosciences knows how to tackle it

Alzheimer's, ALS or a brain injury: ADx neurosciences knows how to tackle it

ADx NeuroSciences might be described best as the Intel of biomarker assays for neuro-degenerative disease. They don’t create complete kits, but their top-notch biomaterials are included in the ass…

Read more

Music or neuroscience? Balthazar’s violinist chose music (at least for now)

Music or neuroscience? Balthazar’s violinist chose music (at least for now)

For Patricia Vanneste, violinist with the popular rock group Balthazar, it wasn’t a choice she made lightly. Patricia has played the violin since she was five. It felt like the perfect hobby, mayb…

Read more

The choroid plexus: where inflammation meets neurology

The choroid plexus: where inflammation meets neurology

We write about change — about impact and consequences, about discoveries and the people behind them. This time, we introduce you to Roosmarijn Vandenbroucke, a discovery scientist at IRC-VIB and a…

Read more

ADHD, a disorder cured by play

ADHD, a disorder cured by play

In 2013, a new BioWin project, NeuroAtt, was launched to arrive at a reliable diagnosis for ADHD (Attention Deficit Hyperactivity Disorder) and to find the least invasive treatment for children. A…

Read more

ALS: A fierce diagnosis

ALS: A fierce diagnosis

Do you remember the Ice Bucket Challenge? Back in 2014, it was used to create awareness and collect donations for research to combat ALS (Amyotrophic Lateral Sclerosis), a severe neurodegenerative…

Read more

Peter Verwilst in Seoul – Belgian scientist living abroad

Peter Verwilst in Seoul – Belgian scientist living abroad

For two and a half years now, Peter Verwilst has been working and living in one of the largest, most vibrant cities in the world, the South Korean capital Seoul. The working pressure is huge in th…

Read more

Ending Alzheimer's before it starts

Ending Alzheimer's before it starts

Sebastiaan Engelborghs is a neurologist specialized in neurodegenerative brain diseases and believes in the potential of early diagnosis for Alzheimer's disease. Engelborghs teaches neuroscienc…

Read more

Birger Dieriks in Auckland - Belgian scientist living abroad

Birger Dieriks in Auckland - Belgian scientist living abroad

Birger Dieriks lives in Auckland, New Zealand. He studied Bioengineering at Ghent University. After finishing his studies he started a PhD at the Department Molecular Biotechnology with Prof Van O…

Read more

Targeting the shape of protein aggregates to treat Parkinson’s

Targeting the shape of protein aggregates to treat Parkinson’s

Parkinson's disease (PD) is the second most common neurodegenerative disorder in the world. Similar to Multiple System Atrophy (MSA) and dementia with Lewy bodies (DLB), it is linked to the aggreg…

Read more

MS slowly but surely unravels its secrets

MS slowly but surely unravels its secrets

Piet Stinissen is Professor and Dean at the Faculty of Medicine and Life Sciences at the University of Hasselt, where he is head of the Immunology and Biochemistry laboratory. He is a biochemist a…

Read more

Alzheimer's can be predicted early

Alzheimer's can be predicted early

Koen Dewaele (CEO) started ADx about three and a half years ago, when Fujirebio (the former Innogenetics), cut back its research activities drastically. Four employees who already worked on Alzhei…

Read more

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Turnstone Flanders.bio Itera Life Science Janssen GSK UGent V-Bio Ventures Biowin XpandInnovation KU Leuven

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.